Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell
Authors:
- 1 December 1994
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 68 (12) , 8001-7
Abstract
The inactivation of type C retroviruses by human serum may be a considerable impediment to the use of retroviral vectors in vivo for gene therapy. Here we show that virus inactivation is dependent both on the virus and on the cell line used to produce the virus. All viruses produced from murine NIH 3T3 or dog Cf2ThS+L- cells are sensitive to human serum. In contrast, those produced from mink Mv-1-Lu and human HOS or TE671 cells are at least partially resistant, with the exception of murine leukemia viruses. In particular, the feline endogenous virus RD114 is completely resistant to a panel of eight human sera when produced from Mv-1-Lu or HOS cells. This differential resistance is controlled by the viral envelope proteins. Virus inactivation can be correlated with the ability of the producer cells to be lysed by human serum. Inactivation of sensitive viruses requires the classical pathway of complement but does not require virion lysis.Keywords
This publication has 25 references indexed in Scilit:
- Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and VaccinesScience, 1992
- Human gene therapy comes of ageNature, 1992
- Anti-cell antibody in macaquesNature, 1991
- ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTIONThe Lancet, 1988
- Human T-cell leukaemia virus is not lysed by human serumNature, 1984
- Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptorNature, 1983
- Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.Journal of Experimental Medicine, 1978
- Selective incorporation of H–2 antigenic determinants into Friend virus particlesNature, 1977
- Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.Journal of Experimental Medicine, 1976
- Human serum lyses RNA tumour virusesNature, 1975